Exodus Point Capital Management, LP Kura Oncology, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.6 Billion
- Q4 2024
A detailed history of Exodus Point Capital Management, LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 297,234 shares of KURA stock, worth $2.46 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
297,234
Previous 54,971
440.71%
Holding current value
$2.46 Million
Previous $1.07 Million
141.06%
% of portfolio
0.02%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding KURA
# of Institutions
196Shares Held
79.6MCall Options Held
98.7KPut Options Held
70.1K-
Black Rock Inc. New York, NY6.97MShares$57.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.8MShares$48 Million0.71% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.08MShares$42 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.82MShares$39.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.45MShares$36.9 Million0.63% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $554M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...